Zobrazeno 1 - 10
of 216
pro vyhledávání: '"D Burkitt"'
Autor:
Katie A. Lloyd, Bryony N. Parsons, Michael D. Burkitt, Andrew R. Moore, Stamatia Papoutsopoulou, Malcolm Boyce, Carrie A. Duckworth, Klaire Exarchou, Nathan Howes, Lucille Rainbow, Yongxiang Fang, Claus Oxvig, Steven Dodd, Andrea Varro, Neil Hall, D. Mark Pritchard
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 10, Iss 1, Pp 113-132 (2020)
Background & Aims: In patients with autoimmune atrophic gastritis and achlorhydria, hypergastrinemia is associated with the development of type 1 gastric neuroendocrine tumors (gNETs). Twelve months of treatment with netazepide (YF476), an antagonist
Externí odkaz:
https://doaj.org/article/fa9e77fa8ab04349aa617d5d954be8d7
Autor:
Alessandra Frau, Umer Z. Ijaz, Rachael Slater, Daisy Jonkers, John Penders, Barry J. Campbell, John G. Kenny, Neil Hall, Luca Lenzi, Michael D. Burkitt, Marieke Pierik, Alistair C. Darby, Christopher S. J. Probert
Publikováno v:
Gut Microbes, Vol 13, Iss 1 (2021)
The etiology of Crohn’s disease (CD) is multifactorial. Bacterial and fungal microbiota are involved in the onset and/or progression of the disease. A bacterial dysbiosis in CD patients is accepted; however, less is known about the mycobiome and th
Externí odkaz:
https://doaj.org/article/a5136c0e2fd0425fa3c6145f461cf2a1
Autor:
Katie Lloyd, Stamatia Papoutsopoulou, Emily Smith, Philip Stegmaier, Francois Bergey, Lorna Morris, Madeleine Kittner, Hazel England, Dave Spiller, Mike H. R. White, Carrie A. Duckworth, Barry J. Campbell, Vladimir Poroikov, Vitor A. P. Martins dos Santos, Alexander Kel, Werner Muller, D. Mark Pritchard, Chris Probert, Michael D. Burkitt, The SysmedIBD Consortium
Publikováno v:
Disease Models & Mechanisms, Vol 13, Iss 11 (2020)
Inflammatory bowel diseases (IBDs) cause significant morbidity and mortality. Aberrant NF-κB signalling is strongly associated with these conditions, and several established drugs influence the NF-κB signalling network to exert their effect. This s
Externí odkaz:
https://doaj.org/article/98e510497b174f5483defce389417b32
Publikováno v:
Disease Models & Mechanisms, Vol 10, Iss 2, Pp 89-104 (2017)
Gastric colonization with Helicobacter pylori induces diverse human pathological conditions, including superficial gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric adenocarcinoma and its precursors. The
Externí odkaz:
https://doaj.org/article/1a40e16da9c7444dae4e3d63f7baa544
Autor:
Stamatia Papoutsopoulou, Michael D. Burkitt, François Bergey, Hazel England, Rachael Hough, Lorraine Schmidt, David G. Spiller, Michael H. R. White, Pawel Paszek, Dean A. Jackson, Vitor A. P. Martins Dos Santos, Gernot Sellge, D. Mark Pritchard, Barry J. Campbell, Werner Müller, Chris S. Probert
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The heterogeneous nature of inflammatory bowel disease (IBD) presents challenges, particularly when choosing therapy. Activation of the NF-κB transcription factor is a highly regulated, dynamic event in IBD pathogenesis. Using a lentivirus approach,
Externí odkaz:
https://doaj.org/article/d581931c5d434a78a70223703dfa1143
Autor:
Awad Mahalhal, Jonathan M Williams, Sophie Johnson, Nicholas Ellaby, Carrie A Duckworth, Michael D Burkitt, Xuan Liu, Georgina L Hold, Barry J Campbell, D Mark Pritchard, Chris S Probert
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0202460 (2018)
Inflammatory bowel disease (IBD) is associated with anaemia and oral iron replacement to correct this can be problematic, intensifying inflammation and tissue damage. The intestinal microbiota also plays a key role in the pathogenesis of IBD, and iro
Externí odkaz:
https://doaj.org/article/094faab6a3de4bcb8cd37152c6ce50f2
Autor:
Bryony N Parsons, Umer Z Ijaz, Rosalinda D'Amore, Michael D Burkitt, Richard Eccles, Luca Lenzi, Carrie A Duckworth, Andrew R Moore, Laszlo Tiszlavicz, Andrea Varro, Neil Hall, D Mark Pritchard
Publikováno v:
PLoS Pathogens, Vol 13, Iss 11, p e1006653 (2017)
Several conditions associated with reduced gastric acid secretion confer an altered risk of developing a gastric malignancy. Helicobacter pylori-induced atrophic gastritis predisposes to gastric adenocarcinoma, autoimmune atrophic gastritis is a prec
Externí odkaz:
https://doaj.org/article/02b332937a5543eca777a7d8e48a013b
Autor:
Jonathan M. Williams, Carrie A. Duckworth, Alastair J. M. Watson, Mark R. Frey, Jennifer C. Miguel, Michael D. Burkitt, Robert Sutton, Kevin R. Hughes, Lindsay J. Hall, Jorge H. Caamaño, Barry J. Campbell, D. Mark Pritchard
Publikováno v:
Disease Models & Mechanisms, Vol 6, Iss 6, Pp 1388-1399 (2013)
SUMMARY The gut barrier, composed of a single layer of intestinal epithelial cells (IECs) held together by tight junctions, prevents the entrance of harmful microorganisms, antigens and toxins from the gut lumen into the blood. Small intestinal homeo
Externí odkaz:
https://doaj.org/article/4630f77e6fe944868eef1669ad069a9d
Autor:
John Penders, Marieke Pierik, Alistair C. Darby, Barry J. Campbell, Neil Hall, Daisy Jonkers, Rachael Slater, Michael D. Burkitt, Luca Lenzi, Chris Probert, John G. Kenny, Umer Zeeshan Ijaz, Alessandra Frau
Publikováno v:
Gut Microbes, 13(1):1930871. Landes Bioscience
Gut Microbes
article-version (VoR) Version of Record
GUT MICROBES
Gut Microbes, Vol 13, Iss 1 (2021)
Gut Microbes
article-version (VoR) Version of Record
GUT MICROBES
Gut Microbes, Vol 13, Iss 1 (2021)
The etiology of Crohn’s disease (CD) is multifactorial. Bacterial and fungal microbiota are involved in the onset and/or progression of the disease. A bacterial dysbiosis in CD patients is accepted; however, less is known about the mycobiome and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb3a2b257d2a33c77dd372dbf56daac
https://cris.maastrichtuniversity.nl/en/publications/138f26b1-9031-4a7d-9918-3fae1db5335b
https://cris.maastrichtuniversity.nl/en/publications/138f26b1-9031-4a7d-9918-3fae1db5335b
Autor:
Andrea Varro, Carrie A. Duckworth, Katie A. Lloyd, Yongxiang Fang, Stamatia Papoutsopoulou, Nathan Howes, Klaire Exarchou, Lucille Rainbow, Andrew R. Moore, D. Mark Pritchard, Neil Hall, Claus Oxvig, Michael D. Burkitt, Steven Dodd, Bryony N. Parsons, Malcolm Boyce
Publikováno v:
Lloyd, K A, Parsons, B N, Burkitt, M D, Moore, A R, Papoutsopoulou, S, Boyce, M, Duckworth, C A, Exarchou, K, Howes, N, Rainbow, L, Fang, Y, Oxvig, C, Dodd, S, Varro, A, Hall, N & Pritchard, D M 2020, ' Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors ', Cellular and Molecular Gastroenterology and Hepatology, vol. 10, no. 1, pp. 113-132 . https://doi.org/10.1016/j.jcmgh.2020.01.010
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 10, Iss 1, Pp 113-132 (2020)
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 10, Iss 1, Pp 113-132 (2020)
Background & Aims In patients with autoimmune atrophic gastritis and achlorhydria, hypergastrinemia is associated with the development of type 1 gastric neuroendocrine tumors (gNETs). Twelve months of treatment with netazepide (YF476), an antagonist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7554914bc0596db17395b9f59dbcfa2f
https://ueaeprints.uea.ac.uk/id/eprint/73860/
https://ueaeprints.uea.ac.uk/id/eprint/73860/